Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
株式のランク #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
株価
$29.82
最終同期: 2023-04-11
時価総額
$223.68M
変化(1日)
1.21%
変化(1年)
0.00%
CA
取引 Neovasc Inc. (NVCN)

カテゴリー

Neovasc Inc.(NVCN)のEPS
2026 時点のEPS TTM: 0
Neovasc Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Neovasc Inc.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS